Hemp Archives - Page 6 of 12 - InvestorWire (IW)

Tuesday Mar 08, 2022 - 9:00 am

Advanced Container Technologies Inc. (ACTX) Is ‘One to Watch’

ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops year-roundACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow PodsATCX is established in the rapidly growing cannabis packaging industryThe company is well positioned in multiple recession-resistant markets Advanced…

Friday Mar 04, 2022 - 9:15 am

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective useThe company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infectionMost recently, the company reported successes in increasing the speed and effectiveness in a drug treating…

Wednesday Mar 02, 2022 - 9:15 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market

Over 140 rare cannabinoids exist in the cannabis plant – some with the potential to have more therapeutic benefits than those cannabinoids found prominently in the plantInMed and subsidiary BayMedica plan to release several rare cannabinoid products in the first half of 2022 Combination of complementary InMed and BayMedica business models key to increasing shareholders’ value In 2020, the global health and wellness market reached $4.436…

Tuesday Mar 01, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Now Controls All Aspects of its Michigan Operations Following PharmaCo’s Acquisition

RWB has received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana companyThis acquisition opens RWB to over 22 properties, including dispensaries and cultivation sites, giving it complete control of all its operations, from cultivating the product to selling itIt marks a key milestone for the company and its shareholders as it continues to execute key components of its growth strategyFor the…

Monday Feb 28, 2022 - 9:15 am

As It Targets Multiple Large Market Opportunities, Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Leveraging Elaborate Studies to Progressively Remove Risks Associated with Commercialization, Regulation

Leveraging the versatility and benefits of its DehydraTECH(TM) technology, Lexaria is targeting multiple large market opportunities as it attempts to ensure it has multiple paths to successThe technology aims to help companies offering oral drugs, supplements, and nicotine formulations to improve the effectiveness of their existing or planned productsLexaria has undertaken various studies whose findings show the benefits of DehydraTECH-processed products relative to controlsThe company…

Thursday Feb 24, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strengthening Expansion with Licensing and Vertical Integration Strategy

Cannabis and hemp multi-state operator Red White & Bloom Brands has established itself in fast-growing plant derivative markets from Michigan to Florida and CaliforniaMichigan’s new legal adult-use market is proving fertile ground for development, and the company has leased manufacturing facilities and obtained full licensing in the stateThanks to the Michigan developments, Red White & Bloom is also expanding distribution of its Platinum Vape gummies…

Friday Feb 18, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Focused On Opportunities in the CBD Industry to Scale Operations

Luis Merchan, Flora Growth’s President and CEO, appeared on a webinar on February 11, 2022, highlighting the opportunities and challenges affecting the CBD industry in key marketsHe has reiterated the company’s commitment to leveraging the industry’s opportunities for the growth of its operations, expansion of its market reach, and value creation for its shareholdersThe CBD industry is projected to be valued at $20 billion by…

Wednesday Feb 16, 2022 - 11:13 am

Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022

Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced positive findings in an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (PDE5 inhibitor) sildenafil as…

Monday Feb 14, 2022 - 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third yearPerhaps most notable among the early-stage research efforts is a study by Oregon State University that found high doses of two specific cannabinoids bound to spike proteins such as COVID’S SARS-CoV-2 and inhibited their potential for infectionCannabis cultivator and brand builder Flora…

Friday Feb 11, 2022 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Shows Promise in Improving Performance, Speed of ED Drugs

Health and wellness drug bio-effectiveness innovator Lexaria Bioscience is advancing human testing of its patented DehydraTECH(TM) technology for the potential treatment of high blood pressure and heart disease Lexaria also recently announced that DehydraTECH boosted the speed and effectiveness of sildenafil in laboratory rats for the potential treatment of erectile dysfunction (“ED”)The company’s statement notes that DehydraTECH-processed sildenafil “delivered 74% more sildenafil into the bloodstream on…

Wednesday Feb 09, 2022 - 10:00 am

The New England Cannabis Convention To Be Held In Boston

Cannabis growers, traders, industry professionals, and enthusiasts are invited to attend the New England Cannabis Convention (“NECANN”), on March 18-20, 2022. NECANN events, organized since 2014 are considered as one of the largest cannabis events on the east coast. The NECANN events attract a huge number of Hemp, MMJ and Cannabis traders/professionals in the Northeast in the annual Boston Cannabis Convention. These events are the…

Tuesday Feb 08, 2022 - 12:34 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Summarizes 2021 Milestones, Outlines 2022 Plans and Expectations, in Annual Letter to Shareholders

In 2021, Lexaria conducted several main studies evaluating DehydraTECH-processed CBD and nicotineThe company has big plans for 2022, a year it expects to undertake three ground-breaking studiesLexaria hopes these three major studies will generate sufficient data to support either regulated IND-type applications or to stimulate corporate partnershipsThe company is eying larger national and international applications for DehydraTECH with the aim of generating revenue through licensing…

Monday Feb 07, 2022 - 12:02 pm

Flora Growth Corp. (NASDAQ: FLGC) Closes January’s Series of Hires, Appointing Joël Reyes as SVP of Global Operations

Joël Reyes’ appointment marks the third appointment in the first month of the 2022 calendar yearMr. Reyes will be responsible for implementing operational excellence across the entire organization, starting with its Columbian activitiesHis appointment comes just in time, following the implementation of the new Colombian law allowing for the export of up to 7,900 kilograms of high-THC cannabis dried flower Flora Growth (NASDAQ: FLGC) embarked…

Friday Feb 04, 2022 - 10:10 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Journey: From Runners’ Knee to Canada’s 101 Top F&B Start-up List

BevCanna Enterprises Inc is a diversified health & wellness beverage and natural products companies which deals in the manufacture and distribution of both, in-house brands, and white-label clientsThe company currently boasts over 3,000 points of distribution and online through which it retails the company’s market-leading TRACE brand, its Pure Therapy natural health products as well as its various, cannabis infused beverages. BevCanna’s strong execution recently saw…

Thursday Feb 03, 2022 - 10:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition

Cannabicitran is the first of four new rare cannabinoids InMed is planning to launch in the first half of the year to meet growing inbound demandThe launch demonstrates InMed’s ability to produce rare cannabinoids at scale, something only very few companies have achievedBayMedica acquisition, other key achievements in 2021, are positioning the company as a leading supplier of rare cannabinoids in the health and wellness…

Wednesday Feb 02, 2022 - 1:57 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Sets to Benefit Amid a Rapidly Growing Market

BevCanna is company developing diversified portfolio of health and wellness products for both in-house brands and white-labeled clientsCompany deploys a traditional retail and direct-to-consumer e-commerce model to offer products throughout North AmericaCompany actively explores opportunities within infused beverages market as CBD-infused beverages gain popularity; global market expected to reach US$2 billion by 2026 BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a Canada-based diversified…

Tuesday Feb 01, 2022 - 2:16 pm

The Alternative Products Expo To Offer Important Networking Opportunities

The Alternative Products Expo arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top…

Tuesday Feb 01, 2022 - 1:17 pm

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefitsInMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoidsAs a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly…

Monday Jan 31, 2022 - 12:35 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Offers a Glimpse into Company’s Unique Technology and Operations on EDGE Podcast

Chris Bunka, the Chairman and CEO of Lexaria, featured on the EDGE podcast hosted by Brandon C. WhiteHe provided insight into his background, professional philosophies, and Lexaria’s operations, with a focus on the company’s patented DehydraTECH(TM) technologyMr. Bunka also advised small companies and entrepreneurs, citing the importance of understanding the competitive environment Chris Bunka, the Chairman and Chief Executive Officer (“CEO”) of Lexaria Bioscience (NASDAQ:…

Thursday Jan 27, 2022 - 11:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Emphasizes Oral Cannabinoid Delivery Benefits Following SARS-CoV-2 Study

The study is available for public viewing and is entitled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” (https://ibn.fm/w6zLQ)Dr. Richard van Breeman, who headed the independent study, explained that smoking and vaping cannabinoids are ineffective against preventing SARS-CoV-2, whereas oral delivery methods are effectiveLexaria has been studying and researching the oral delivery of compounds using its patented DehydraTECH(TM) technology, which enhances bioavailability and…

Thursday Jan 27, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Gains Full Cannabis Licensing to Rise in Michigan’s Developing Recreational Use Market

Multi-state cannabis operator Red White & Bloom Brands is developing opportunities strategically in sizable cannabis markets such as Michigan, Florida, Illinois, California, Arizona, Oklahoma and MassachusettsThe company recently announced it has secured full licensing for manufacturing both medical and adult use cannabis products in Michigan, one of its key marketsRed White & Bloom has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and…

Wednesday Jan 26, 2022 - 12:15 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market

The global cannabinoid-based pharmaceuticals market is projected to be valued at $50 billion by 2029InMed is leading the industry, laying down the foundation in manufacturing and clinical development of rare cannabinoidsIt is shedding light on the potential of rare cannabinoids and laying the groundwork on how to tap into the industry’s growth It is projected that by 2025, the global cannabis market will be valued…

Monday Jan 24, 2022 - 12:49 pm

Flora Growth Corp. (NASDAQ: FLGC) Kicks off 2022 with Successful First Cannabis Extraction at new Colombia Facility, the Appointment of Tim Leslie as Advisory Board Chairman, and 360 Financial Inc.’s FLGC stock purchase

Flora Growth just announced the production of its first batch of crude oil through its newly constructed facility in ColombiaThe company has also initiated the EU-GMP certification process that will allow it to target international medical cannabis marketsFlora Growth also announced the appointment of Tim Leslie as Chairman of its newly established Advisory BoardMr. Leslie will play a key role in advising the company on…

Thursday Jan 20, 2022 - 1:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Great Start to its 2022 R&D Programs Following Independent Review Board Approval

Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatmentThe stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1All of these 2022 R&D programs are fully funded, with Lexaria having raised approximately $15 million over the 2021 calendar yearLexaria believes that these programs will build significant value for its stakeholders…

Tuesday Jan 18, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in 2021, Year in Review

RWB marked 2021 with strategic acquisitions, with the most notable of them being Acreage Holdings Inc. and a 45,000 square foot greenhouse in Apopka, FloridaThese strategic investments would see the company steadily grow its revenue, marking a 93% year-over-year growth by Q3The year also marked notable appointments, including Ryan Costello and Colby De Zen, both into the company’s Board of DirectorsRWB is confident that the…

Friday Jan 14, 2022 - 9:00 am

After a Successful 2021, Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off 2022 With New Media Strategy, Plans for Clinical Study Advancements

Lexaria has multiple studies planned that will commence early in 2022 DehydraTECH increases Lexaria’s ability to leverage multiple markets, including the growing CBD sector, which is expected to meet and exceed $108 billion in revenue by 2027 DehydraTECH can increase the efficacy of the drugs being administered, offering faster absorption and lowering the delivery time In a strategic move to start off 2022, Lexaria Bioscience…

Thursday Jan 13, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Targeting Increased Revenue and Margins with Strategic Focus on Vertical Integration

RWB recently reported its Q3 2021 financial results in which revenues grew 93% YOYThe company is pursuing vertical integration in multiple states, including Florida, California, and MichiganIn Florida, RWB has launched cultivation operations and a processing facility expected to provide additional inventory for its Springhill dispensary, as well as three new dispensaries set to be opened in Q1 2022According to RWB Chairman and CEO Brad…

Wednesday Jan 12, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Distribution Deal Increases CBD Product Reach to Mexico, Latin America

Plant-based wellness and lifestyle brand cultivator Flora Growth Corp. is building on its initial revenues from 2021 with distribution expansion into Mexico The company will initially distribute a portfolio of 12 Mind Naturals skincare products through e-commerce but intends to eventually locate its products in brick-and-mortar storesThe company’s deal with Mexican department store Coppel gives it a reach nationwide through its online marketplace and, perhaps eventually,…

Wednesday Jan 12, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates Productive Year for Blood Pressure Drug Solution with Eye on Advancing Clinical Studies in 2022

Lexaria Bioscience’s ongoing human clinical studies for its patented and trademarked DehydraTECH technology have yielded progressively optimistic results in 2021 regarding DehydraTECH’s ability to provide effective solutions for the cardiovascular industryDehydraTECH is being studied for its capacity to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulationDehydraTECH-CBD underwent three human clinical…

Tuesday Jan 11, 2022 - 10:05 am

Q3 Report Notes Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Revenue Growth of 93 percent YOY

Red White & Bloom Brands is a cannabis multi-state operator building on opportunities in Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts to create a synergistic portfolio throughout North AmericaRWB is also building its hemp-based CBD products retail throughout the United States and into international marketsThe company has released its third quarter financial report on revenue growth, operational development and progress in finalizing additional agreementsThe…

Monday Jan 10, 2022 - 9:53 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 studyThe approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human studyHYPER-H21-4 should "de-risk" outcomes prior to Lexaria's planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular…

Friday Jan 07, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

2021 marked the year when Flora Growth held its IPO - the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC"It also marked the year when the company ventured into the European market, as well as other key regions such as MexicoSignificant acquisitions for the 2021 calendar year included Koch & Gsell, Vessel Brand Inc., and GMP-Certified…

Thursday Jan 06, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Increases Investor Visibility with SRAX Inc. (NASDAQ: SRAX)

The strategic move to incorporate SRAX is designed to bring investor visibility for all of the upcoming events that Lexaria has planned for 2022Lexaria’s patented DehydraTECH(TM) technology is poised to leverage multiple industries – notably the CBD industry, with a projected value of $108.8 billion by 2027The advertising and media contract will allow SRAX to engage and manage social media companies for the creation and…

Wednesday Jan 05, 2022 - 12:51 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Named as One of the Top 101 Food and Beverage Startups and Companies in Canada

Best Startup Canada named BevCanna Enterprises one of the 101 Top Food and Beverage Startups and Companies in CanadaBevCanna was also recognized as one of the Top 101 Cannabis Startups in the countryThe company has had strong growth momentum in its core business, with 3Q21 revenues rising over 1,000% year-over-yearBevCanna signed an agreement to manufacture and white-label cannabis beverages on behalf of Averi Health Products,…

Monday Jan 03, 2022 - 12:24 pm

Flora Growth Corp. (NASDAQ: FLGC) Entering 2022 with Momentum from Sustainability Efforts and the Building of Global Distribution Channels

Flora Growth Corp. is a Canadian cannabis and wellness brand distributor operating from a cultivation base in central ColombiaThe company’s focus on sustainability guides its efforts to market products that are beneficial to their local communities as well as the world at largeMarket analysts predict 2022 will see the global CBD skin care market segment alone grow with a CAGR of 24.8 percentThe COVID-19 pandemic…

Thursday Dec 30, 2021 - 9:30 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Named Exclusive Water Partner for Canada’s Country Music Week 2021; BevCanna Named One of 101 Top Food and Beverage Startups and Companies in Canada

BevCanna Enterprises announced that its in-house brand, TRACE was designated as the exclusive water partner for the Country Music Week 2021The TRACE brand features a range of products sourced from springs located deep within the Rocky Mountains; the product range includes Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water and Natural Flavor Sparkling Spring Water among othersBevCanna Enterprises separately announced that it has been named…

Tuesday Dec 28, 2021 - 9:30 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Reports Strong Third Quarter 2021 Financial Results; Sees Revenues Soar by Upwards of 1,000% YoY

BevCanna Enterprises recently published its unaudited financial results for the third quarter of 2021The company recorded over 1,000% revenue growth year-over-year which separately recording positive gross profit for the quarterIn addition to receiving its initial orders from the British Columbia, Alberta and Ontario Cannabis Distribution companies, BevCanna has also signed an agreement with UNFI Canada – thus leading to a significant expansion in its geographical…

Monday Dec 27, 2021 - 1:27 pm

Flora Growth Corp. (NASDAQ: FLGC) Marks 2021 Close with Product Diversification and Market Expansion

Flora Growth recently expanded into Mexico and Spain with its Mind Naturals and Awe CBD skincare brandsAdditionally, the company ventured into the dry herb market through Vessel brand, its wholly owned subsidiaryThe recent licensing agreement with Tonino Lamborghini marks Flora Growth’s aggressive product diversification plan that has defined its 2021 calendar yearAll the decisions and moves made by the company so far have been geared…

Monday Dec 27, 2021 - 1:11 pm

Marijuana Company of America Inc. (MCOA) Completes VBF Brands Acquisition, Highlighting Growth Strategy

Marijuana Company of America, Inc. has been expanding its portfolio in recent months through acquisitions and partnerships designed to enhance the company’s revenue streamMCOA’s trademarked hempsmart brand of CBD products has been joined by verticals including marijuana cultivator and distributor VBF Brands, CBD brands distributor cDistro, in-store advertiser VapeTV US, and other industry solutionsThe recent completion of VBF Brands’ acquisition grants MCOA efficiency and sustainable…

Monday Dec 27, 2021 - 1:02 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expects Study Results to Show its Patented Tech’s Value in Treating Hypertension Patients

Lexaria Bioscience is preparing to file an Investigational New Drug application with the U.S. Food and Drug Administration for its patented technology’s use in treating hypertension (high blood pressure)The company has completed multiple studies of the benefits of DehydraTECH(TM), in combination with cannabidiol to combat hypertension conditions and consequentially benefit cardiovascular patientsLexaria recently announced that it is nearing completion of a third human study in…

Articles

Articles Category: Hemp

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions